Global Heel Incision Devices Market is valued approximately at USD 183.87 million in 2022 and is anticipated to grow with a growth rate of more than 2.99% over the forecast period 2023-2030. Heel incision devices are efficient and safe medical devices specifically designed for infants. These tools offer an efficient way to collect blood samples from newborn and preterm infants' heels. The heel incision devices are regarded safe, and this technology is a retractable safety technique for capillary blood sample. Rising birth rates globally, growing focus on technological advancement in medical device manufacturing and rising expenditure on healthcare infrastructure development, particularly in developing economies, rising awareness about multi-specialty products and the availability of infant care products is also bolstering the heel incision devices market growth. Mandatory new born testing policy adopted in several countries will further drive the heel incision devices market growth rate.

Moreover, the growing cases of premature births can indeed support the growth of the Heel Incision Devices Market. The Premature babies are at a higher risk of developing health complications, and they require frequent monitoring and diagnostic tests to ensure their well-being. Heel incision devices are commonly used to obtain blood samples for tests such as blood gas analysis, bilirubin level monitoring, and other critical assessments. The rise in premature births will result in a greater need for these diagnostic tests, thus increasing the demand for heel incision devices. According to Statista, in 2015, percentage of preterm births in the United States was 9.63% and the percentage reached 10.09% in 2020. As a result, the rising prevalence of premature births is anticipated to create the lucrative demand for the market. Additionally, rising technological advancement in healthcare, along with an ever-increasing population, will provide even more profitable heel incision devices market growth potential. However, lack of professional and medical expertise is anticipated to further derail the heel incision devices market growth rate during forecast period 2023-2030.

The key regions considered for the Global Heel Incision Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to presence of key market players, rising prevalence of premature births, growing investment in medical industry, and continues technological advancement in the region. Asia Pacific is expected to fastest growing during the forecast period, as the population grows, so does the need for medical services and equipment. The adoption of advanced solutions by healthcare organizations and hospitals may increase demand for contemporary medical gadgets like devices for heel incisions.

Major market player included in this report are:
Becton, Dickinson and Company
Owen Mumford Ltd.
Cardinal Health International India Pvt Ltd
Smiths Medical, Inc.
Clinical Innovations, LLC
MediCore Inc.
Vitrex Medical A/S
NSP Medicals
Torvan Medical Inc.
Medtronic
Recent Developments in the Market:
In February 2020, LABORIE Medical Technologies, a leading diagnostic and therapeutic medical technology company, acquired Clinical Innovations. LLC. This drives the demand for newborn screening test and need of heel incision devices.
Global Heel Incision Devices Market Report Scope:
Historical Data: 2020 - 2021
Base Year for Estimation: 2022
Forecast period: 2023-2030
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product Type, Application, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Micro- preemie
Preemie
New born and Infant
By Application:
Hospitals
Speciality Clinics
Ambulatory Surgical Centres
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa